Table 1.

Direct and indirect mechanisms involved in cancer-associated thrombosis

TargetCancer cell–derived factor to induce prothrombotic statusAction
Coagulation cascade Increased TF expression Thrombin and fibrin generation
Platelet activation by thrombin 
PAI-1 Inhibited fibrinolysis 
Platelets ADP release Platelet aggregation via P2Y1 and P2Y12 and adhesion to cancer cells 
Podoplanin Platelet aggregation via CLEC-2 and adhesion to cancer cells 
Other Neutrophils Any factors derived from cancer NET generation and subsequent activation of platelets and FXII by NETs 
Platelets and neutrophils IL-6 (stimulate TPO generation in the liver), G-CSF secretion Granulocytosis and thrombocytosis 
Mucins Aggregation via P-selectin in platelets and L-selectin in neutrophils 
Endothelial cells Inflammatory cytokines Prothrombotic change 
TargetCancer cell–derived factor to induce prothrombotic statusAction
Coagulation cascade Increased TF expression Thrombin and fibrin generation
Platelet activation by thrombin 
PAI-1 Inhibited fibrinolysis 
Platelets ADP release Platelet aggregation via P2Y1 and P2Y12 and adhesion to cancer cells 
Podoplanin Platelet aggregation via CLEC-2 and adhesion to cancer cells 
Other Neutrophils Any factors derived from cancer NET generation and subsequent activation of platelets and FXII by NETs 
Platelets and neutrophils IL-6 (stimulate TPO generation in the liver), G-CSF secretion Granulocytosis and thrombocytosis 
Mucins Aggregation via P-selectin in platelets and L-selectin in neutrophils 
Endothelial cells Inflammatory cytokines Prothrombotic change 

ADP, adenosine 5′-diphosphate; CLEC-2, C-type lectin-like receptor 2; FXII, factor XII; G-CSF, granulocyte colony-stimulating factor; IL-6, interleukin 6; NET, neutrophil extracellular trap; PAI-1, plasminogen activator inhibitor 1; TF, tissue factor; TPO, thrombopoietin.

Close Modal

or Create an Account

Close Modal
Close Modal